T. Rowe Price Associates’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.7M | Buy |
265,944
+34,007
| +15% | +$1.55M | ﹤0.01% | 1179 |
|
|
2025
Q4 | $10.3M | Buy |
231,937
+18,061
| +8% | +$778K | ﹤0.01% | 1229 |
|
|
2025
Q3 | $9.03M | Buy |
213,876
+15,054
| +8% | +$607K | ﹤0.01% | 1253 |
|
|
2025
Q2 | $7.29M | Buy |
198,822
+13,078
| +7% | +$486K | ﹤0.01% | 1188 |
|
|
2025
Q1 | $7.08M | Buy |
185,744
+19,013
| +11% | +$707K | ﹤0.01% | 1180 |
|
|
2024
Q4 | $6.31M | Buy |
166,731
+20,880
| +14% | +$834K | ﹤0.01% | 1231 |
|
|
2024
Q3 | $5.94M | Buy |
145,851
+9,801
| +7% | +$371K | ﹤0.01% | 1245 |
|
|
2024
Q2 | $4.66M | Buy |
136,050
+2,884
| +2% | +$90.8K | ﹤0.01% | 1242 |
|
|
2024
Q1 | $4.22M | Buy |
133,166
+3,466
| +3% | +$105K | ﹤0.01% | 1261 |
|
|
2023
Q4 | $3.98M | Buy |
129,700
+16,413
| +14% | +$527K | ﹤0.01% | 1277 |
|
|
2023
Q3 | $3.76M | Sell |
113,287
-2,228
| -2% | -$71.2K | ﹤0.01% | 1249 |
|
|
2023
Q2 | $3.55M | Sell |
115,515
-1,093,271
| -90% | -$31.6M | ﹤0.01% | 1289 |
|
|
2023
Q1 | $33.1M | Buy |
1,208,786
+2,442
| +0.2% | +$68K | 0.01% | 797 |
|
|
2022
Q4 | $33.7M | Buy |
1,206,344
+3,043
| +0.3% | +$91.8K | 0.01% | 771 |
|
|
2022
Q3 | $35.5M | Buy |
1,203,301
+22,970
| +2% | +$720K | 0.01% | 748 |
|
|
2022
Q2 | $33.3M | Buy |
1,180,331
+225,225
| +24% | +$6.41M | ﹤0.01% | 1007 |
|
|
2022
Q1 | $29.8M | Buy |
955,106
+826,115
| +640% | +$24.4M | ﹤0.01% | 1128 |
|
|
2021
Q4 | $3.82M | Sell |
128,991
-6,422
| -5% | -$188K | ﹤0.01% | 1536 |
|
|
2021
Q3 | $4.06M | Sell |
135,413
-1,634
| -1% | -$56.2K | ﹤0.01% | 1540 |
|
|
2021
Q2 | $4.97M | Buy |
137,047
+4,441
| +3% | +$165K | ﹤0.01% | 1505 |
|
|
2021
Q1 | $4.86M | Buy |
132,606
+1,348
| +1% | +$49.6K | ﹤0.01% | 1471 |
|
|
2020
Q4 | $4.77M | Sell |
131,258
-4,690
| -3% | -$159K | ﹤0.01% | 1450 |
|
|
2020
Q3 | $4.07M | Sell |
135,948
-2,223
| -2% | -$69.4K | ﹤0.01% | 1426 |
|
|
2020
Q2 | $4.11M | Sell |
138,171
-12,641
| -8% | -$374K | ﹤0.01% | 1404 |
|
|
2020
Q1 | $4M | Buy |
150,812
+29,803
| +25% | +$1.13M | ﹤0.01% | 1368 |
|
|
2019
Q4 | $5.13M | Buy |
121,009
+6,099
| +5% | +$258K | ﹤0.01% | 1391 |
|
|
2019
Q3 | $4.8M | Sell |
114,910
-82,529
| -42% | -$3.21M | ﹤0.01% | 1384 |
|
|
2019
Q2 | $7.26M | Buy |
197,439
+134,402
| +213% | +$4.9M | ﹤0.01% | 1359 |
|
|
2019
Q1 | $2.4M | Buy |
63,037
+670
| +1% | +$24.8K | ﹤0.01% | 1530 |
|
|
2018
Q4 | $2.19M | Buy |
62,367
+748
| +1% | +$25.9K | ﹤0.01% | 1538 |
|
|
2018
Q3 | $2.02M | Sell |
61,619
-6,606
| -10% | -$210K | ﹤0.01% | 1620 |
|
|
2018
Q2 | $2.12M | Buy |
68,225
+368
| +0.5% | +$10.5K | ﹤0.01% | 1582 |
|
|
2018
Q1 | $1.83M | Buy |
67,857
+442
| +0.7% | +$11.8K | ﹤0.01% | 1597 |
|
|
2017
Q4 | $1.86M | Buy |
67,415
+109
| +0.2% | +$3.15K | ﹤0.01% | 1603 |
|
|
2017
Q3 | $2.15M | Hold |
67,306
| – | – | ﹤0.01% | 1559 |
|
|
2017
Q2 | $2.22M | Buy |
67,306
+4,410
| +7% | +$146K | ﹤0.01% | 1532 |
|
|
2017
Q1 | $2.08M | Buy |
62,896
+13
| +0% | +$418 | ﹤0.01% | 1574 |
|
|
2016
Q4 | $1.97M | Buy |
62,883
+12
| +0% | +$370 | ﹤0.01% | 1568 |
|
|
2016
Q3 | $2.23M | Buy |
62,871
+10
| +0% | +$355 | ﹤0.01% | 1522 |
|
|
2016
Q2 | $2.13M | Buy |
62,861
+23,320
| +59% | +$778K | ﹤0.01% | 1508 |
|
|
2016
Q1 | $1.4M | Buy |
39,541
+6,020
| +18% | +$197K | ﹤0.01% | 1616 |
|
|
2015
Q4 | $1.17M | Buy |
33,521
+371
| +1% | +$12.8K | ﹤0.01% | 1646 |
|
|
2015
Q3 | $1.17M | Hold |
33,150
| – | – | ﹤0.01% | 1662 |
|
|
2015
Q2 | $1.14M | Hold |
33,150
| – | – | ﹤0.01% | 1713 |
|
|
2015
Q1 | $1.34M | Hold |
33,150
| – | – | ﹤0.01% | 1659 |
|
|
2014
Q4 | $1.29M | Hold |
33,150
| – | – | ﹤0.01% | 1662 |
|
|
2014
Q3 | $1.13M | Hold |
33,150
| – | – | ﹤0.01% | 1698 |
|
|
2014
Q2 | $1.22M | Buy |
33,150
+2,100
| +7% | +$74.9K | ﹤0.01% | 1676 |
|
|
2014
Q1 | $1.04M | Hold |
31,050
| – | – | ﹤0.01% | 1681 |
|
|
2013
Q4 | $925K | Sell |
31,050
-2,100
| -6% | -$66.5K | ﹤0.01% | 1696 |
|
|
2013
Q3 | $990K | Hold |
33,150
| – | – | ﹤0.01% | 1669 |
|
|
2013
Q2 | $1.03M | Buy |
+33,150
| New | +$1.09M | ﹤0.01% | 1644 |
|
Other funds holding OHI
VPM
VCM
T. Rowe Price Associates's OHI Position: Q1 2026 in Review
T. Rowe Price Associates increased its Omega Healthcare (OHI) stake by 15% in Q1 2026, buying an estimated $1.55M and bringing the position to 265,944 shares worth $11.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1179.
T. Rowe Price Associates first reported a position in OHI in Q2 2013 and has held it in 52 quarters since. The position peaked at $35.5M in Q3 2022. 743 funds tracked by Wall St. Rank hold OHI as of Q1 2026.
- T. Rowe Price Associates held 265,944 shares of Omega Healthcare worth $11.7M as of Q1 2026.
- T. Rowe Price Associates bought 34,007 Omega Healthcare shares in Q1 2026, an estimated $1.55M.
- Omega Healthcare made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1179 holding.
- T. Rowe Price Associates first reported a position in Omega Healthcare in Q2 2013 and has held it in 52 quarters since.
- T. Rowe Price Associates's Omega Healthcare position peaked at $35.5M in Q3 2022.
- 743 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.